U.S. markets closed

Bruker Corporation (BRKR)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
Visitors trend2W10W9M
67.65-0.22 (-0.32%)
At close: 4:00PM EDT

67.65 0.00 (0.00%)
After hours: 4:19PM EDT

Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Fast Stochastic

Fast Stochastic

Performance Outlook
Previous Close67.87
Open68.11
Bid67.64 x 800
Ask67.66 x 1300
Day's Range67.07 - 68.11
52 Week Range34.79 - 70.61
Volume610,703
Avg. Volume462,309
Market Cap10.253B
Beta (5Y Monthly)1.30
PE Ratio (TTM)66.32
EPS (TTM)1.02
Earnings DateMay 05, 2021
Forward Dividend & Yield0.16 (0.24%)
Ex-Dividend DateMar 04, 2021
1y Target Est67.42
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued
-15% Est. Return
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
View more
  • Bruker Corporation (BRKR) Reports Solid Preliminary Q1 Revenues
    Zacks

    Bruker Corporation (BRKR) Reports Solid Preliminary Q1 Revenues

    Bruker's (BRKR) revenue improvement in the first quarter is likely to have been boosted by robust performance by all three of its BSI groups.

  • Bruker Announces First Quarter 2021 Preliminary Revenue
    Business Wire

    Bruker Announces First Quarter 2021 Preliminary Revenue

    Bruker Corporation (Nasdaq: BRKR) today announced preliminary revenue for the first quarter ended March 31, 2021 in a range of $549 - $554 million, representing reported revenue growth of approximately 30% to 31%, compared to the first quarter of 2020. Adjusting for the impact of foreign currency translation and acquisitions, Bruker estimates non-GAAP organic revenue growth in the first quarter of 2021 of approximately 22% to 23% year-over-year. This compares favorably to the Company’s earlier outlook for greater than 15% organic growth for the first quarter.

  • Investor's Business Daily Video

    Bruker Relative Strength Line Improving

    Bruker may be setting up as it trades sideways the past week. Another one from the blue dot screen on MarketSmith.